TY - JOUR
T1 - Soft tissue sarcoma, version 2.2016
T2 - Clinical practice guidelines in oncology
AU - Von Mehren, Margaret
AU - Randall, R. Lor
AU - Benjamin, Robert S.
AU - Boles, Sarah
AU - Bui, Marilyn M.
AU - Conrad, Ernest U.
AU - Ganjoo, Kristen N.
AU - George, Suzanne
AU - Gonzalez, Ricardo J.
AU - Heslin, Martin J.
AU - Kane, John M.
AU - Koon, Henry
AU - Mayerson, Joel
AU - McCarter, Martin
AU - McGarry, Sean V.
AU - Meyer, Christian
AU - O'Donnell, Richard J.
AU - Pappo, Alberto S.
AU - Paz, I. Benjamin
AU - Petersen, Ivy A.
AU - Pfeifer, John D.
AU - Riedel, Richard F.
AU - Schuetze, Scott
AU - Schupak, Karen D.
AU - Schwartz, Herbert S.
AU - Tap, William D.
AU - Wayne, Jeffrey D.
AU - Bergman, Mary Anne
AU - Scavone, Jillian
N1 - Publisher Copyright:
© 2016 National Comprehensive Cancer Network, Inc., All rights reserved.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for Soft Tissue Sarcoma (available at NCCN.org) provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumor, desmoid tumors, and rhabdomyosarcoma. This manuscript discusses guiding principles for the diagnosis and staging of STS and evidence for treatment modalities that include surgery, radiation, chemoradiation, chemotherapy, and targeted therapy.
AB - Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Guidelines for Soft Tissue Sarcoma (available at NCCN.org) provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as intra-abdominal/retroperitoneal STS, gastrointestinal stromal tumor, desmoid tumors, and rhabdomyosarcoma. This manuscript discusses guiding principles for the diagnosis and staging of STS and evidence for treatment modalities that include surgery, radiation, chemoradiation, chemotherapy, and targeted therapy.
UR - http://www.scopus.com/inward/record.url?scp=85010208871&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2016.0078
DO - 10.6004/jnccn.2016.0078
M3 - Article
C2 - 27283169
AN - SCOPUS:85010208871
SN - 1540-1405
VL - 14
SP - 758
EP - 786
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 6
ER -